Cecilie Fredvik Torkildsen
Stilling
Førsteamanuensis
Tilhørighet
Publikasjoner
Vitenskapelig artikkel
- Luka Tandaric; Line Bjørge; Martine Rott Lode et al. (2026). Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. (ekstern lenke)
- Kathinka Schmidt Slørdahl; Katarina Puco; Ragnhild Sørum Falk et al. (2026). Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial. (ekstern lenke)
- Kjetil Søreide; Torhild Veen; Elen Martine Hauge et al. (2025). The gender gap between female medical students and recruitment to surgical training in Norway: A cross-sectional, nationwide cohort study of medical students, surgical trainees, and specialists. (ekstern lenke)
- Kjetil Søreide; Elen Martine Hauge; Cecilie Fredvik Torkildsen et al. (2025). Time-trend analysis of female rates among certified surgeon specialists across 10 surgical specialties in Norway. (ekstern lenke)
- Malin Andrea Elisabeth Dögl; Pål Richard Romundstad; Line Dahlgaard Berntzen et al. (2018). Elective induction of labor: A prospective observational study. (ekstern lenke)
- Karine Eid; Øivind Fredvik Grytten Torkildsen; Jan Harald Aarseth et al. (2021). Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study. (ekstern lenke)
- Karine Eid; Øivind Torkildsen; Jan Harald Aarseth et al. (2022). Association of adverse childhood experiences with the development of multiple sclerosis. (ekstern lenke)
- Cecilie Fredvik Torkildsen; Ragnar Kvie Sande; Katrine Kirial et al. (2021). En gravid kvinne med akutte magesmerter. (ekstern lenke)
- Karine Eid; Øivind Torkildsen; Jan Harald Aarseth et al. (2022). Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. (ekstern lenke)
- Cecilie Fredvik Torkildsen; Liv Cecilie Vestrheim Thomsen; Ragnar Sande et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (ekstern lenke)
- Katrin Kleinmanns; Stein-Erik Gullaksen; Geir Bredholt et al. (2022). Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. (ekstern lenke)
- Cecilie Fredvik Torkildsen; Marie Austdal; Ann-Charlotte Iversen et al. (2023). Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins. (ekstern lenke)
- Cecilie Fredvik Torkildsen; Marie Austdal; Anders Hagen Jarmund et al. (2024). New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients. (ekstern lenke)
- Katarina Puco; Gro Live Fagereng; Sigmund Brabrand et al. (2024). IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results. (ekstern lenke)